Pancreatic Ductal Adenocarcinoma Clinical Trials in Newport Beach, California

4 studies are recruiting for pancreatic ductal adenocarcinoma in Newport Beach, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

    This is a multi-center, non-randomized, single-arm, open-label, phase Ib, dose escalation/dose expansion study of PTM-101 when combined with neoadjuvant chemotherapy for the treatment of treatment-naïve subjects with borderline resectable and locally advanced pancreatic ductal adenocarcinoma (PDAC).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Hoag Memorial Hospital Presbyterian, Newport Beach, California
    Locations
    8 in total
    Run by
    PanTher Therapeutics

    See if you can join NCT06673017 on ClinicalTrials.gov

  2. Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

    Phase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, Newport Beach, California
    Locations
    18 in total
    Run by
    AstraZeneca

    See if you can join NCT06218914 on ClinicalTrials.gov

  3. Pancreatic Cancer Early Detection Consortium

    The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Hoag, Newport Beach, California
    Locations
    60 in total
    Run by
    Arbor Research Collaborative for Health

    See if you can join NCT04970056 on ClinicalTrials.gov

  4. Pancreatic Cancer Detection Consortium

    This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Hoag Center, Newport Beach, California
    Locations
    11 in total
    Run by
    City of Hope Medical Center

    See if you can join NCT06388967 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.